Abstract Thromboxane A2 (TXA2) and angiotensin II (Ang II) stimulate vascular smooth muscle hypertrophy by upregulating endogenous synthesis of basic fibroblast growth factor (bFGF). Because 
The methods for culture of rat aortic vascular smooth muscle cells (VSMCs) and the measurement of protein and DNA synthesis have been previously described in detail.1 '15 Briefly, VSMCs were cultured from rat aortas by outgrowth from explants. All cells used in these studies were from subcultures 3 through 6 and stained positively for a-smooth muscle actin. Before stimulation with thromboxane mimetic, Ang II, or PMA, cells were growth-arrested by culture for 48 hours in serum-free medium supplemented with 10 ,ug/mL insulin and transferrin. Protein synthesis was estimated by incorporation of For rat brain, 2 ,uL of cDNA and 10 pmol PKC 1 and 2 primers were used. For both samples, 30 pmol of 4' and 4 primers were used. Amplifications were performed for 35 cycles at 94°C for 30 seconds, 60°C for 30 seconds, and 72°C for 90 seconds, followed by elongation at 72°C for 420 seconds. PCR products were visualized on 1.5% agarose gels and vacuum-blotted onto Hybond N+ (Amersham) for isoform confirmation by Southern hybridization using 32P-labeled PKC isoform-specific oligonucleotide probes.
The identity of the PCR products was further confirmed by sequence analysis and comparison with known sequences in the GenBank database. PCR fragments were blunt-ended with Klenow and subcloned into Hinc-cut pBluescript (Stratagene). Double-stranded sequencing was performed by SEQUENASE, version 2.0 (United States Biochemicals).
Immunoblot Analysis of bFGF
After stimulation with agonists or vehicle, cells were eluted from culture flasks with trypsin-versine, washed twice with ice-cold phosphate-buffered saline, and frozen at -80C for up to 2 weeks. bFGF was assayed by Western analysis as previously described.3 Briefly, vascular smooth muscle heparinbinding proteins were concentrated by incubation of equal amounts of sample protein with heparin-conjugated agarose and then size-separated over sodium dodecyl sulfate (SDS)-polyacrylamide gels. Proteins were electroblotted onto nitrocellulose membranes, and bFGF was identified by binding to monoclonal anti-bFGF and visualized with anti-mouse IgG conjugated to horseradish peroxidase by chemiluminescence. Inhibition of bFGF production using an antisense oligodeoxynucleotide was performed as previously described.3 '13 Immunoblot Analysis of PKC Isoforms Quiescent VSMCs were stimulated as appropriate for the individual experiment, washed twice with phosphate-buffered saline (pH 7.4), scraped from the tissue culture substrates, and collected in 50 mmol/L Tris (pH 7.5), 5 immunoblot analysis of heparin-binding proteins. Fig 3, top, shows that each of the three agents studied increased the expression of 18-, 21-, and 22-kD isoforms of rat bFGF over a 6-to 24-hour period. In contrast, the inactive phorbol ester PDD had no effect on VSMC bFGF expression (see below). Parallel Neither calphostin C nor staurosporine increased VSMC bFGF levels in quiescent unstimulated cells (data not shown). As shown in Fig 5, 8 , and E (as in Fig 2, bottom left) . As shown in Fig 7, downregulation of these PKC isoforms with PMA significantly inhibited the hypertrophic response to both agonists compared with treatment with the inactive phorbol ester. In contrast, seruminduced growth was not affected by PMA pretreatment.
Discussion
In the present study, the effects of PKC activation in vasoconstrictor-stimulated vascular smooth muscle hypertrophy were examined. The results of experiments in which PKC was activated by using PMA were compared with those in which PKC was inhibited during TXA2- One of the more remarkable findings of these studies is that calphostin C also greatly attenuated vascular smooth muscle leucine and thymidine uptake in response to 20 ng/mL exogenously applied bFGF. Taken together, these results show that increased bFGF expression in TXA2-stimulated or Ang TI-stimulated VSMCs can be independent of PKC activation. However, bFGF formation alone is not sufficient for cellular hypertrophy, because activation of PKC is required to transduce the bFGF growth response. Thus, PKC activation is critical for vasoconstrictor-induced hypertrophy at a point downstream from bFGF in the cell-signaling cascade. 
